Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.

Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL. Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol. 2010 Dec; 184(6):2303-7.

View in: PubMed